Avricore Health Boasts Robust Mid-Year Financials

Avricore Health (TSE:AVCR) has released an update.

Avricore Health Inc. has reported significant mid-year financial growth for 2024, with a 84% increase in revenue and a net profit of $222,559. The company attributes its success to strong partnerships, a dedicated team, and a mission focused on improving access to healthcare. With consecutive profitable quarters and a solid increase in working capital, Avricore is showing potential for further growth in the healthcare sector.

For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.